Rabbit Recombinant Monoclonal TGFBI antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 7 publications.
View Alternative Names
BIGH3, TGFBI, Transforming growth factor-beta-induced protein ig-h3, Beta ig-h3, Kerato-epithelin, RGD-containing collagen-associated protein, RGD-CAP
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TGFBI antibody [EPR12079(B)] (AB169771)
Immunohistochemical analysis of paraffin-embedded Human uterus tissue labeling TGFBI with ab169771 at 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TGFBI antibody [EPR12079(B)] (AB169771)
Immunohistochemical analysis of paraffin-embedded Human colon adenocarcinoma tissue labeling TGFBI with ab169771 at 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-TGFBI antibody [EPR12079(B)] (AB169771)
All lanes:
Western blot - Anti-TGFBI antibody [EPR12079(B)] (ab169771) at 1/1000 dilution
Lane 1:
Human fetal kidney tissue lysate at 10 µg
Lane 2:
Human small intestine lysate at 10 µg
Lane 3:
Mouse eyeball lysate at 10 µg
Lane 4:
Rat small intestine lysate at 10 µg
Secondary
All lanes:
HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 75 kDa
false
- WB
CiteAb
Western blot - Anti-TGFBI antibody [EPR12079(B)] (AB169771)
TGFBI western blot using anti-TGFBI antibody [EPR12079(B)] ab169771. Publication image and figure legend from Lv, J., Wang, Z., et al., 2017, J Diabetes Res, PubMed 28713834.
ab169771 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab169771 please see the product overview.
SYFSF inhibited renal fibrosis in DKD rats. (a–d) Immunohistochemical staining of TGF-β1, collagen IV, and fibronectin is shown. (e, f) Western blot and quantitative analysis of TGF-β1 in the cortex. SYFSF and irbesartan inhibited the expression of TGF-β1 in DKD rats. DKD + S represents the DKD rats treated with SYFSF. DKD + I represents the DKD rats treated with irbesartan. *p < 0.05, **p < 0.01, and ***p < 0.001.
false
Related conjugates and formulations (1)
-
Anti-TGFBI antibody [EPR12079(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Iranian journal of public health 53:2260-2270 PubMed39544858
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed38790949
2024
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 65:21 PubMed38190126
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:581517 PubMed33414782
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:18100 PubMed31792315
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of diabetes research 2017:4319057 PubMed28713834
2017
Applications
WB, IHC
Species
Unspecified reactive species, Unspecified reactive species
The British journal of dermatology 175:302-13 PubMed26972571
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com